We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 179 start-ups with an aggregate funding of $3.5b. The average funding per company in this subset is $51.0m.
Last update to the database: Feb 18, 2025. See changelog.
Neos Therapeutics is a pharmaceutical company developing ADHD medications founded in 2008.
1
Funding Rounds
$24.1m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
16
Funding Rounds
$328.8m
Money raised
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
9
Funding Rounds
$82.6m
Money raised
Nanomedicine company developing vaccines and therapies with cell-specific targeting.
6
Funding Rounds
$4.6m
Money raised
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
6
Funding Rounds
$86.6m
Money raised
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.
3
Funding Rounds
$143.4m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
CeQur is a wearable mealtime insulin device maker founded in 2008 by Joël Besse.
2
Funding Rounds
$56.6m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
4
Funding Rounds
$46.7m
Money raised
CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.
2
Funding Rounds
$645.0k
Money raised
TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.
2
Funding Rounds
$22.2m
Money raised
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$5.9m
Money raised
Tempo Therapeutics is an interventional biomaterials for regenerative medicine company founded by Westbrook Weaver.
1
Funding Rounds
$3.9m
Money raised
Xycrobe Therapeutics is a biotechnology company developing microbiome-Based, biotherapeutic delivery systems.
1
Funding Rounds
$400.0k
Money raised
Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.
3
Funding Rounds
$121.0m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
3
Funding Rounds
$50.6m
Money raised
A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.
1
Funding Rounds
$2.0m
Money raised
A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.
5
Funding Rounds
$93.6m
Money raised
A pharmaceutical company developing oral therapies for chronic diseases.
1
Funding Rounds
$21.6m
Money raised
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
1
Funding Rounds
CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.
13
Funding Rounds
$123.5m
Money raised
Diabeloop is a Grenoble-based company founded in 2015.
3
Funding Rounds
$191.8m
Money raised
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.
1
Funding Rounds
$22.8m
Money raised
Orexo is a pharmaceutical company developing and commercializing drugs founded in 1995 by Anders Pettersson, Christer Nyström and Thomas Lundqvist.
2
Funding Rounds
$72.9m
Money raised
Entos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.
1
Funding Rounds
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
3
Funding Rounds
$152.8m
Money raised
PepVax Inc. is a Washington DC-based biotechnology company.
2
Funding Rounds
$8.5m
Money raised
GenEdit develops technology for gene editing.
3
Funding Rounds
$34.5m
Money raised
Carmine Therapeutics is a Cambridge, Massachusetts-based company developing novel types of gene therapies utilizing extracellular vesicles produced in laboratory.
1
Funding Rounds
$3.4m
Money raised
RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy.
1
Funding Rounds
$594.1k
Money raised
PDX Pharmaceuticals, Inc. is a company in the pharmaceuticals industry founded by Wassana Yantasee in 2010.
2
Funding Rounds
$5.6m
Money raised
Bionaut Labs develops precision medicine treatments for CNS disorders.
2
Funding Rounds
$20.0m
Money raised
Bigfoot Biomedical is an insulin delivery pump founded in 2014.
4
Funding Rounds
$194.9m
Money raised
Corium International is a transdermal Generics, Consumer Products founded in 1999.
1
Funding Rounds
$40.0m
Money raised
leon-nanodrugs is a Bayern, Germany-based company that specializes in researching and developing nanotechnology-based drugs.
2
Funding Rounds
$22.3m
Money raised
Sixfold Bioscience is a biotechnology firm focused on advancing RNA therapies founded in 2017 by Anna Perdrix Rosell, Zuzanna Brzosko and George Foot.
1
Funding Rounds
$10.0m
Money raised
Collegium Pharmaceutical is a company developing products for pain management founded in 2002.
1
Funding Rounds
$22.5m
Money raised
AmacaThera is a hydrogel-based drug delivery founded in 2016 by Molly Shoichet.
3
Funding Rounds
$16.4m
Money raised
Pantec Biosolutions AG develops drug delivery solutions for a variety of medical applications.
1
Funding Rounds
$6.9m
Money raised
SiSaf is the first company to create a Bio-Courier platform technology.
4
Funding Rounds
NanoMedical Systems is a personalized Molecular Drug-delivery System Implant founded in 2007 by Mauro Ferrari, David D. Saathoff and Randy Goodall.
5
Funding Rounds
$12.2m
Money raised
Micro-organosphere technologies to guide precision therapy for cancer patients
3
Funding Rounds
$92.0m
Money raised
Gilero is a Morrisville, North Carolina-based company offering device design, development, and contract manufacturing services in the medical and pharmaceutical industries.
1
Funding Rounds
$11.5m
Money raised
Sensulin is an insulin manufacturing company founded by Ananth Annapragada, Mike Moradi, Chris Rhodes and Dan Bradbury.
2
Funding Rounds
$330.0k
Money raised
Lyndra Therapeutics is a drug Delivery founded in 2015.
3
Funding Rounds
$143.0m
Money raised
Vesigen Therapeutics is a company in Cambridge, Massachusetts.
1
Funding Rounds
$2.9m
Money raised
VALANX Biotech is a company enabling antibody drug conjugates
1
Funding Rounds
$2.4m
Money raised
Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases
2
Funding Rounds
$150.0m
Money raised
Pharmaco-Kinesis Corporation is a high-end medical device technology company.
2
Funding Rounds
$17.2m
Money raised
Pharnext is a very well advanced clinical-stage biopharmaceutical company
3
Funding Rounds
$19.9m
Money raised
Flexion Therapeutics is an american biotechnology company founded in 2007.
2
Funding Rounds
$53.0m
Money raised
A company developing precision drug delivery systems and products
2
Funding Rounds
$30.1m
Money raised
Periphagen is a biopharmaceutical company founded in 2012 by Darren Wolfe
2
Funding Rounds
$22.5m
Money raised
Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.
1
Funding Rounds
$3.1m
Money raised
A medical device company developing surgical renal denervation for the treatment of hypertension
3
Funding Rounds
$159.3m
Money raised
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics.
2
Funding Rounds
$321.0m
Money raised
InCarda Therapeutics is a company developing therapies for cardiovascular diseases founded in 2009 by Carlos A. Schuler.
2
Funding Rounds
$72.1m
Money raised
Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment.
1
Funding Rounds
$1.6m
Money raised
Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.
1
Funding Rounds
$3.0m
Money raised
CF PharmTech is a specialty Respiratory Pharmaceuticals founded in 2007.
1
Funding Rounds
$65.0m
Money raised
3Bar Biologics is a microbe delivery and manufacturing company that partners with microbe discovery and commercialization companies.
2
Funding Rounds
$3.0m
Money raised
BioLight Life Sciences Ltd. is devoted to the development of products and diagnostic solutions for ophthalmic conditions.
2
Funding Rounds
$10.2m
Money raised
Microdermics is a skincare company founded in 2014 by Grant Campany, Boris Stoeber, Sahan Ranamukhaarachchi and Iman Mansoor.
2
Funding Rounds
$1.5m
Money raised
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
3
Funding Rounds
$12.0m
Money raised
410 Medical Inc is an emergency Infusion Device founded in 2013.
7
Funding Rounds
$27.6m
Money raised
Ring Therapeutics is a multi-product platform company.
2
Funding Rounds
$167.0m
Money raised
2C Tech Corporation, Inc. is a nanoparticles for Ophthalmology founded by Naresh Mandava.
3
Funding Rounds
$5.5m
Money raised
Adocia is a molecular Delivery System for Therapeutic Proteins founded in 2005.
4
Funding Rounds
$57.1m
Money raised
Chameleon Biosciences Inc. is a gene therapy company.
2
Funding Rounds
$3.1m
Money raised